HomeLopinavir And RitonavirLopinavir And Ritonavir + Efavirenz

Does Lopinavir And Ritonavir Interact with Efavirenz?

Lopinavir And Ritonavir and Efavirenz have a moderate drug interaction according to U.S. FDA drug labeling data. Efavirenz decreases lopinavir concentrations. Once daily dosing not recommended when coadministered. The mechanism involves cyp3a and cyp2b6 induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Lopinavir And Ritonavir Class
Protease Inhibitor
Efavirenz Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Lopinavir And Ritonavir and Efavirenz occurs because cyp3a and cyp2b6 induction. Clinically, this means efavirenz decreases lopinavir concentrations. once daily dosing not recommended when coadministered. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Lopinavir And Ritonavir and your doctor is considering prescribing Efavirenz (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Lopinavir And Ritonavir(Kaletra)+💊 Efavirenz(Symfi)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Protease Inhibitor
Drug B class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Source
NLP:efavirenz

What this means in plain English

Efavirenz decreases lopinavir concentrations. Once daily dosing not recommended when coadministered.

About Lopinavir And Ritonavir and Efavirenz

Lopinavir And Ritonavir is a Protease Inhibitor, while Efavirenz is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. You may recognize them by the brand names Kaletra and Symfi. Both medications are taken by mouth.

What the FDA label says

"CYP3A and CYP2B6 induction"

📖 Source: NLP:efavirenz

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Lopinavir And Ritonavir and Efavirenz against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.